Says growth platform provides a clear line of sight into the next decade. Says pleased with breadth and depth of pipeline. Expects important product approvals over next two years. Expects to invest $10B of capital in U.S over next ten years. Says long term outlook is “very strong.” Comments taken from Q3 earnings conference call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- Morning Movers: Brighthouse Financial surges after take-private deal report
- Options Volatility and Implied Earnings Moves Today, October 31, 2025
- AbbVie raises dividend 5.5%, beginning with dividend payable in February, 2026
- AbbVie raises FY25 adjusted EPS view to $10.61-$10.65 from $10.38-$10.58
- AbbVie raises quarterly dividend 5.5% to $1.73 from $1.64 per share